In this interview, Sebastiaan J. Trietsch, Chief Technology Officer at MIMETAS, discusses how microphysiological systems are ...

Researchers have developed an oral antiviral drug candidate for COVID-19 that could overcome major limitations of Paxlovid, ...

The development of long-acting drug depots represents a significant advancement in pharmaceutical technology, offering ...

In attempt to keep R&D costs low, the vivarium business model has emerged as a crucial solution for drug developers.

Ace Therapeutics, a pioneering leader in diabetes preclinical research solutions, develops a variety of animal models for diabetic wounds (DW), such as the excisional wound splinting model, to assist ...

Alzheimer's disease, the most common cause of dementia, is currently incurable. The current drugs available have very limited efficacy and only in mild stages of the disease.